Global private equity and venture capital news and research

Posts Tagged ‘Flagship Ventures’

13 August 2014

VC-backed blood diagnostics business picks up $16m Series B round

blood drop Venture capital-backed blood collection and diagnostic business Seventh Sense Biosystems has picked up $16m of Series B financing.

15 July 2014

Flagship brings aboard ex-Merck & Co exec Pomerantz as senior partner

Roger Pomerantz Flagship Ventures Healthcare-focused early stage investment firm Flagship Ventures has hired former Merck & Co senior vice president Roger Pomerantz as a senior partner.

18 February 2014

Flagship-founded food nutrion developer Pronutria gets $12.25m Series B

microscope7_sq Flagship Ventures has led a $12.25m Series B financing round for nutrition supplement and medical food-developer Pronutria.

7 February 2014

Eleven Biotherapeutics raises $50m via IPO

dollar envelope money Venture capital-backed biopharmaceutical company Eleven Biotherapeutics has raised $50m via an IPO on the Nasdaq exchange.

25 November 2013

Flagship, Polaris, Third Rock lead $43m Series A for Editas Medicine

biotech_lrg Flagship Ventures, Polaris Partners and Third Rock Ventures have led a $43m Series A for genome editing specialist Editas Medicine.

20 November 2013

Venture capital-backed Moderna Therapeutics secures $110m

dollar envelope money Biotech startup Moderna Therapeutics has raised a $110m round, which took its fundraising total to $415m.

26 September 2013

Venture-backed cancer treatment company BIND raises $70.5m through IPO

BIND Therapeutics Venture capital-backed BIND Therapeutics has raised $70.5m through an IPO of its shares on the Nasdaq Global Select Market.

11 June 2013

Third Rock, Flagship-backed Agios files for $86m Nasdaq IPOp

dna Venture capital-backed Agios Pharmaceuticals has filed to raise $86m through an IPO five years after picking up its first tranche of early-stage funding.

22 May 2013

Flagship Ventures names Stephane Bancel as senior partner

Healthcare and sustainability-focused VC firm Flagship Ventures has appointed Stephane Bancel as a senior partner.

12 April 2013

Syros raises $30m from ARCH Venture Partners and Flagship Ventures

Newly launched cancer treatment specialist Syros Pharmaceuticals has secured $30m in Series A funding for the development of its gene control medicines.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014